Satter Management Co., L.P. Annexon, Inc. Transaction History
Satter Management Co., L.P.
- $89.6 Million
- Q1 2024
A detailed history of Satter Management Co., L.P. transactions in Annexon, Inc. stock. As of the latest transaction made, Satter Management Co., L.P. holds 7,406,024 shares of ANNX stock, worth $35.8 Million. This represents 59.29% of its overall portfolio holdings.
Number of Shares
7,406,024
Previous 7,406,024
-0.0%
Holding current value
$35.8 Million
Previous $33.6 Million
57.93%
% of portfolio
59.29%
Previous 46.3%
Shares
4 transactions
Others Institutions Holding ANNX
# of Institutions
138Shares Held
87.3MCall Options Held
2.54MPut Options Held
556K-
Bain Capital Life Sciences Investors, LLC Boston, MA8.7MShares$42 Million9.43% of portfolio
-
Bvf Inc San Francisco, CA7MShares$33.8 Million1.5% of portfolio
-
Redmile Group, LLC San Francisco, CA5.5MShares$26.6 Million1.56% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.16MShares$24.9 Million0.09% of portfolio
-
Black Rock Inc. New York, NY5.04MShares$24.4 Million0.0% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $230M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...